Fixed Cycle and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT

Authors
Category Primary study
ConferenceAnnual Meeting of the American Academy of Neurology, AAN 2025
Year 2025
This article has no abstract
Epistemonikos ID: b345bc187b7a5c1ae49677c9097d963c2eeea459
First added on: Sep 12, 2025